Plasma Levels of Platelet and Vascular Prostaglandin Derivatives in Children with Sickle Cell Anaemia

Summary

Platelet and vascular endothelial prostaglandin derivatives were measured by radioimmunoassay in the plasma of 39 children with homozygous sickle cell anaemia and 27 control subjects. The levels of both thromboxane B₂ and 6-keto-PGF_1α, the stable endproducts of platelet and vascular prostaglandin metabolism, were significantly (p <0.001) greater in sickle cell anaemia plasma than in the plasma of the controls. There were no differences in levels of either 6-keto-PGF_1α or thromboxane B₂ between steady state and vaso-occlusive crisis in the sickle cell patients. Injury to the endothelial lining of blood vessels may occur in sickle cell anaemia as a consequence of contact with the abnormal erythrocytes.

Keywords

Sickle cell anaemia - Platelets - Prostaglandin - Thromboxane - Prostacyclin

• References

• 1 Gruppo RA, Glueck HI, Granger SM, Miller MA. Platelet function in sickle cell anaemia. Thromb Res 1977; 10: 325-335
• 2 Haut MJ, Cowan DH, Harris JW. Platelet function and survival in sickle cell disease. J Lab Clin Med 1973; 82: 44-53
• 3 Ritter JM, Blair IA, Barrow SE, Dollery CT. Release of prostacyclin in vivo and its role in man. Lancet 1983; 01: 317-319
• 4 Majerus PW. Arachidonate metabolism in vascular disorders. J clin Invest 1983; 72: 1521-1525
• 5 Bunting S, Moncada S, Vane JR. The prostacyclin-thromboxane A₀₂ balance: pathophysiological and therapeutic implications. Br Med Bull 1973; 39: 271-276
• 6 Mehta P, Albiol L. Prostacyclin and platelet aggregation in sickle cell disease. Pediatrics 1982; 70: 354-356
• 7 Mehta P. Increased plasma thromboxane levels in sickle cell disease. Pediatr Res 1981; 15: 582
• 8 Mankad VN, Longenecker G. Platelet and endothelial prostanoids in sickle cell disease. Pediatr Res 1983; 17: 237A (Abstr)
• 9 Stuart MJ, Sills RH. Deficiency of plasma prostacyclin or PGI₀₂ regenerating ability in sickle cell anaemia. Br J Haematol 1981; 48: 545-550
• 10 Salmon JA. Measurement of eicosanoids by bioassay and radioimmunoassay. Br Med Bull 1983; 39: 227-231
• 11 Zar JH. Biostatistical Analysis. Englewood Cliffs N J: Prentice-Hall, Inc.; 1974: 152-154
• 12 Greaves M, Preston FE. Plasma 6-keto-prostaglandin F_1α: fact or fiction. Thromb Res 1982; 26: 145-157
• 13 Belch JJF, Greer I, McLaren M. et al. Measurement of prostacyclin metabolites. Lancet 1983; 02: 1504
• 14 Butt RW, Buchanan MR. Basal 6-keto-PGF_1α levels: influence of sampling techniques. Thromb Res 1983; 29: 469-470
• 15 Ditter H, Heinrich D, Matthias FR. et al. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of β-thromboglobulin, platelet factor 4, thromboxane B₀₂, 6-keto-prostaglandin F_1α, and heparin. Thromb Res 1983; 32: 393-408
• 16 Stockman JA, Nigro MA, Mishkin MM, Oski FA. Occlusion of large cerebral vessels in sickle-cell anaemia. N Engl J Med 1972; 287: 846-849
• 17 Buchanan GR, Holtkamp CA. Platelet aggregation, malondial-dehyde generation and production time in children with sickle cell anaemia. Thromb Haemostas 1981; 46: 690-693
• 18 Buchanan GR, Holtkamp CA. Evidence against enhanced platelet activity in sickle cell anaemia. Br J Haematol 1983; 54: 595-603
• 19 Greenberg J, Ohene-Frempong K, Halus J. et al. Trial of low doses of aspirin as prophylaxis in sickle cell disease. J Pediatr 1983; 102: 781-784
• 20 Richardson SGN, Matthews KB, Stuart J. et al. Serial changes in coagulation and viscosity during sickle-cell crisis. Br J Haematol 1979; 41: 95-103
• 21 Kenny MW, George AJ, Stuart J. Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism. J Clin Pathol 1980; 33: 622-625
• 22 Hebbel RP, Yamada O, Moldow CF. et al. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium. Possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest 1980; 65: 154-160
• 23 Mackie I, Bull H, Brozovic M. Altered factor VIII complexes in sickle cell disease. Br J Haematol 1980; 46: 499
• 24 Sarji KE, Eurenius K, Fullwood CO, Schraibman HB, Colwell JA. Abnormalities of platelet aggregation in sickle cell anemia. Presence of a plasma factor inhibiting aggregation by ristocetin. Thromb Res 1979; 14: 283